Cite

MLA Citation

    Yuta Suzuki and Hiroshi Ishihara. “Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs.” Drug metabolism and pharmacokinetics, vol. 41, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100146765462.0x000036
  
Back to record